Mei Ri Jing Ji Xin Wen·2025-11-13 05:57Core Viewpoint - The actual controller of Jiuzhou Pharmaceutical has changed as Huaxuande transfers his shares to his daughters, resulting in a shift in control to them due to Huaxuande's advanced age [1][9]. Shareholding Structure - Huaxuande transferred 42.5% of his shares in Zhejiang Zhongbei Jiuzhou Group and 10% in Taizhou Gede Industrial to his daughters, with Huaxuande no longer holding any shares post-transfer [3][9]. - After the transfer, Huaxuande's daughters hold 22.17% and 13.36% of Jiuzhou Pharmaceutical, respectively, while Huaxuande exits the role of actual controller [1][9]. Financial Details - The total consideration for the share transfer was approximately 61.115 million yuan for Zhongbei Group and 700,000 yuan for Taizhou Gede [9]. - The estimated market value of the shares transferred, based on Jiuzhou Pharmaceutical's stock price of 20.23 yuan per share, is approximately 2.5191 billion yuan [7][9]. Background Information - Huaxuande, born in 1943, is the founder of Jiuzhou Pharmaceutical and has gradually stepped back from management roles due to age, having resigned from key positions since 2017 [11][12]. - Jiuzhou Pharmaceutical transitioned from producing chemical raw materials to contract custom development and production since 2008, and it was listed on the Shanghai Stock Exchange in 2014 [11].